210 related articles for article (PubMed ID: 35806930)
1. Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group.
Ozenne A; De Berti M; Body G; Carcopino X; Graesslin O; Kerbage Y; Akladios C; Huchon C; Bricou A; Mimoun C; Raimond E; Ouldamer L;
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806930
[TBL] [Abstract][Full Text] [Related]
2. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
3. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
4. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
[TBL] [Abstract][Full Text] [Related]
5. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
[TBL] [Abstract][Full Text] [Related]
6. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text].
Bourdel N; Huchon C; Cendos AW; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chéreau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):223-235. PubMed ID: 32004780
[TBL] [Abstract][Full Text] [Related]
7. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Diagnosis and Management of Recurrent Borderline Ovarian Tumours].
Gauroy E; Larouzée E; Chéreau E; De La Motte Rouge T; Margueritte F; Sallée C; Lacorre A; Gauthier T; Koskas M
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):314-321. PubMed ID: 32004781
[TBL] [Abstract][Full Text] [Related]
8. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group.
Sangnier E; Ouldamer L; Bendifallah S; Huchon C; Collinet P; Bricou A; Mimoun C; Lecointre L; Graesslin O; Raimond E
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101961. PubMed ID: 33127559
[TBL] [Abstract][Full Text] [Related]
10. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
[TBL] [Abstract][Full Text] [Related]
11. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.
Uzan C; Nikpayam M; Ribassin-Majed L; Gouy S; Bendifallah S; Cortez A; Rey A; Duvillard P; Darai E; Morice P
Ann Oncol; 2014 Jul; 25(7):1312-1319. PubMed ID: 24713312
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Borderline Ovarian Tumor Recurrence Rate after Surgery with or without Fertility-Sparing Approach: Results of a Retrospective Analysis.
Pecorino B; Laganà AS; Mereu L; Ferrara M; Carrara G; Etrusco A; Di Donna MC; Chiantera V; Cucinella G; Barra F; Török P; Scollo P
Healthcare (Basel); 2023 Jul; 11(13):. PubMed ID: 37444757
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.
Trillsch F; Mahner S; Woelber L; Vettorazzi E; Reuss A; Ewald-Riegler N; de Gregorio N; Fotopoulou C; Schmalfeldt B; Burges A; Hilpert F; Fehm T; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Baumann K; Keyver-Paik MD; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schroeder W; Muenstedt K; Richter B; Kommoss F; Hauptmann S; du Bois A
Ann Oncol; 2014 Jul; 25(7):1320-1327. PubMed ID: 24618151
[TBL] [Abstract][Full Text] [Related]
14. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution.
Sozen H; Vatansever D; Topuz S; Iyibozkurt C; Kandemir H; Yalçin I; Onder S; Yavuz E; Salihoglu Y
J Obstet Gynaecol; 2019 Feb; 39(2):253-258. PubMed ID: 30372646
[TBL] [Abstract][Full Text] [Related]
16. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
[TBL] [Abstract][Full Text] [Related]
17. Predictive features of borderline ovarian tumor recurrence in patients with childbearing potential undergoing conservative treatment.
Capozzi VA; Cianci S; Scarpelli E; Monfardini L; Cianciolo A; Barresi G; Ceccaroni M; Sozzi G; Mandato VD; Uccella S; Franchi M; Chinatera V; Berretta R
Mol Clin Oncol; 2022 Jul; 17(1):121. PubMed ID: 35761896
[TBL] [Abstract][Full Text] [Related]
18. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Surgical Management of Advanced Stages of Borderline Ovarian Tumours].
Raimond E; Bourdel N
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):304-313. PubMed ID: 32004785
[TBL] [Abstract][Full Text] [Related]
19. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
[TBL] [Abstract][Full Text] [Related]
20. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S;
Eur J Cancer; 2013 May; 49(8):1905-14. PubMed ID: 23490647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
